Introduction
The kinase cyclin B-Cdc2/Cdk1 is a universal regulator of M phase (Nurse, 1990) . After the cyclin B-Cdk1 complex is first formed, its activity is regulated by the balance of activity between Wee1/Myt1 kinase that phosphorylates Cdk1 for inhibition and Cdc25 phosphatase that dephosphorylates the Wee1/Myt1 sites for activation (Lew and Kornbluth, 1996) . At the G2/M phase border, the cyclin B-Cdk1 complex is already present but is kept inactive because the balance is inclined to the inhibitory phos phorylation. At the initial onset of M phase, the balance is tipped to initially activate a small population of cyclin B-Cdk1. Sub sequently, a much larger population of cyclin B-Cdk1 becomes activated through an autoregulatory loop in which active cy clin B-Cdk1 further inactivates Wee1/Myt1 and activates Cdc25 (Lew and Kornbluth, 1996; Ferrell et al., 2009; Lindqvist et al., 2009 ). An additional core element of the autoregulatory loop is the cyclin B-Cdk1-dependent inhibition of protein phosphatase 2A (PP2A)-B55, the phosphatase that antagonizes the effects of cyclin B-Cdk1 on Wee1/Myt1 and Cdc25 (Mochida and Hunt, 2012) . In this inhibitory PP2AB55 pathway, cyclin B-Cdk1 activates Greatwall kinase (Gwl; Yu et al., 2006) ; Gwl in turn phosphorylates the small protein endosulfine (Ensa) and/or its close relative cyclic adenosine monophosphate-regulated phos phoprotein 19 (Arpp19); and then phosphorylated Ensa/Arpp19 suppresses PP2AB55 activity (Zhao et al., 2008; Castilho et al., 2009; Mochida et al., 2009 Mochida et al., , 2010 Vigneron et al., 2009; Gharbi Ayachi et al., 2010; Lorca et al., 2010; Rangone et al., 2011; Kim et al., 2012) .
However, inconsistencies exist in the literature as to whether Gwl is always required for cyclin B-Cdk1 activation. Gwl is essential for cyclin B-Cdk1 activation or entry into M phase in cycling extracts from frog eggs (Yu et al., 2006) and in many types of fruit fly cells (Yu et al., 2004) . In contrast, Gwl is not always required for human cell proliferation because some cells strongly depleted of Gwl/MASTL are delayed in G2 phase but finally enter into M phase Voets and E ntry into M phase is governed by cyclin B-Cdk1, which undergoes both an initial activation and subsequent autoregulatory activation. A key part of the autoregulatory activation is the cyclin B-Cdk1-dependent inhibition of the protein phosphatase 2A (PP2A)-B55, which antagonizes cyclin B-Cdk1. Greatwall kinase (Gwl) is believed to be essential for the autoregulatory activation because Gwl is activated downstream of cyclin B-Cdk1 to phosphorylate and activate -endosulfine (Ensa)/Arpp19, an inhibitor of PP2A-B55. However, cyclin B-Cdk1 becomes fully activated in some conditions lacking Gwl, yet how this is accomplished remains unclear. We show here that cyclin B-Cdk1 can directly phosphorylate Arpp19 on a different conserved site, resulting in inhibition of PP2A-B55. Importantly, this novel bypass is sufficient for cyclin B-Cdk1 autoregulatory activation. Gwl-dependent phosphorylation of Arpp19 is nonetheless necessary for downstream mitotic progression because chromosomes fail to segregate properly in the absence of Gwl. Such a biphasic regulation of Arpp19 results in different levels of PP2A-B55 inhibition and hence might govern its different cellular roles.
Cyclin B-Cdk1 inhibits protein phosphatase PP2A-B55 via a Greatwall kinase-independent mechanism
To characterize Arpp19 in starfish oocytes, we raised in rabbits two types of antibodies against starfish Arpp19: antifulllength Arpp19 (antiArpp19) and anti-phosphoSer106 of Arpp19 (antipSer106) antibodies (Fig. S2, A and B ). Arpp19 protein was detectable in immature oocytes ( Fig. 1 B) , a major fraction of which localized to the cytoplasm (Fig. 1 C) . During Wolthuis, 2010). Even more strikingly, Gwl is absolutely un necessary in meiosis I of starfish oocytes (see following para graph; Hara et al., 2012) ; and the nematode Caenorhabditis elegans has no obvious Gwl kinase (Kim et al., 2012) . It is thus possible that other pathways may act to shut down the activity of PP2A B55 during the autoregulatory activation of cyclin B-Cdk1.
Immature oocytes generally arrest their cell cycle at the G2/M phase border of the first meiosis (Kishimoto, 2003) . The meiotic G2/M phase transition in starfish oocytes is induced by the extracellular action of the maturationinducing hormone 1methyladenine (1MeAde; Kanatani et al., 1969) , which results in the intracellular activation of cyclin B-Cdk1 with no require ment for new protein synthesis (Kishimoto, 2011) . In starfish oocytes as well as in fruit fly (Yu et al., 2004) and human Voets and Wolthuis, 2010) so matic cells, Gwl is exclusively present in the nucleus (germinal vesicle) and is activated downstream of cyclin B-Cdk1. When Gwl activity is depleted either by prior enucleation from imma ture oocytes (Kishimoto et al., 1981) or by injection of neutral izing antiGwl antibody that can inhibit Gwl activity , cyclin B-Cdk1 is activated nearly normally . It is thus intriguing to ask how the autoregulatory activa tion of cyclin B-Cdk1 is accomplished in the absence of Gwl. We show here that cyclin B-Cdk1 directly phosphorylates Arpp19 on a different conserved site to inhibit PP2AB55, resulting in the autoactivation of cyclin B-Cdk1 without Gwl.
Results and discussion
Arpp19 is required for cyclin B-Cdk1 activation regardless of the presence or absence of Gwl PP2AB55 is known to be largely cytoplasmic in both fruit fly (MayerJaekel et al., 1994) and mammalian cells (Santos et al., 2012; ÁlvarezFernández et al., 2013) . It is thus conceivable that inhibition of PP2AB55 is accomplished after 1MeAde addition in enucleated (i.e., Gwldepleted) starfish oocytes as well because inhibition of PP2AB55 is thought to be required for full activa tion of cyclin B-Cdk1. Consistently, phosphorylated FizzySer50 (FizzypSer50; see Materials and methods), a major phosphatase of which is PP2AB55 , was dephosphory lated in enucleated immature oocytes, whereas it remained at the phosphorylated state after 1MeAde treatment ( Fig. 1 A) .
We then examined whether Ensa/Arpp19 is required for activation of cyclin B-Cdk1 in enucleated oocytes. For this pur pose, a cDNA of starfish homologue of Ensa/Arpp19 was first isolated (Fig. S1 ). Although only a single homologue of Ensa/ Arpp19 was found, this is a commonly encountered phenome non in starfish (Abe et al., 2010) . In fact, database searches re vealed that there is also a single homologue of Ensa/Arpp19 in the C. elegans, fruit fly, sea urchin, and amphioxus genomes, suggesting that invertebrates have a only one homologue of Ensa/Arpp19. Because the starfish homologue was more similar to Arpp19 than Ensa, it is hereafter called starfish Arpp19. A putative phosphorylation site targeted by Gwl is conserved at Ser106 in starfish Arpp19. Figure 1 . Arpp19 is required for cyclin B-Cdk1 activation regardless of the presence or absence of nucleus. (A) PP2A-B55 activity is possibly suppressed after 1-MeAde addition in enucleated as well as nucleated oocytes. Fizzy-pSer50 was injected into nucleated or enucleated oocytes at G2 phase (1-MeAde untreated, ) or M phase (1-MeAde treated, +; at a time equivalent to GVBD). 15 min later, phosphorylation states of Fizzy-Ser50 were analyzed by Western blot. Asterisk, nonspecific band. (B) Anti-Arpp19 antibody inhibits cyclin B-Cdk1 activation in nucleated oocytes. Immature oocytes were uninjected (none) or injected with either anti-Arpp19 antibody or control IgG, and then treated with 1-MeAde. After collection of oocytes at the indicated times, immunoblots were performed with the indicated antibodies. Numbers on the right indicate molecular mass. (C) Arpp19 is largely cytoplasmic. Protein amounts in immature oocytes were compared with immunoblots. Gwl is a nuclear marker and cyclin B is a cytoplasmic marker. (D) Anti-Arpp19 antibody inhibits cyclin B-Cdk1 activation also in enucleated oocytes. After enucleation (which removes Gwl), oocytes were injected and treated as in B. Note that even after 1-MeAde addition, phospho-Tyr15 in Cdk1 (pTyr15) remained detectable and Cdc25 remained inactive in anti-Arpp19 antibody-injected nucleated (B) and enucleated (D) oocytes. Brightness, contrast, and gamma settings were adjusted in the image presentation.
the meiotic G2/M phase transition, protein levels of Arpp19 remained constant, whereas its mobility on SDSPAGE became slightly retarded. The levels of Ser106 phosphorylation greatly increased in parallel with activation of both cyclin B-Cdk1 and Gwl, which were indicated by disappearance of phospho Tyr15 on Cdk1 and by hyperphosphorylation of Gwl, respectively ( Fig. 1 B, none) .
When nucleated immature oocytes were injected with antiArpp19 antibody and then treated with 1MeAde, no ger minal vesicle breakdown (GVBD) was observed. Consistently, cyclin B-Cdk1 failed to become activated and no increase oc curred in the levels of Arpp19Ser106 phosphorylation ( Fig. 1 B,  antiArpp19 ). These observations support the ideas that the anti Arpp19 antibody suppresses the effect of endogenous Arpp19 and that Arpp19 is necessary for activation of cyclin B-Cdk1 in nucleated oocytes. In enucleated immature oocytes as well, no activation of cyclin B-Cdk1 was observed when they were injected with the neutralizing antiArpp19 antibody and then treated with 1MeAde ( Fig. 1 D) . Arpp19 is thus required for cyclin B-Cdk1 activation even in the absence of Gwl.
Arpp19 is phosphorylated on Ser69 by cyclin B-Cdk1 in vitro and in vivo
How can Arpp19 be involved in cyclin B-Cdk1 activation if Gwl is not present? To address this, we first examined more closely the behavior of Arpp19 in enucleated, Gwlfree oocytes ( Fig. 2 A) . Although no phosphorylation was detectable on Ser106 of Arpp19 when cyclin B-Cdk1 became activated after 1MeAde addition to enucleated oocytes, a slight shiftup in Arpp19's elec trophoretic mobility nevertheless occurred. Changes in the phos phorylation pattern of Arpp19 before and after cyclin B-Cdk1 activation in enucleated oocytes were even clearer using phostag SDSPAGE ( Fig. 2 B, particularly the P 1 band). When recombi nant Gwl was added back to enucleated oocytes, the P 1 band dis appeared, whereas the P 3 band appeared ( Fig. 2 C) , supporting that the major effect of enucleation is removal of Gwl. Arpp19 is thus most likely phosphorylated in enucleated oocytes by some mitotic kinase other than Gwl.
Ensa/Arpp19 has been reported to be phosphorylated not only by Gwl but also by cyclin B-Cdk1 in M phase, although the role for cyclin B-Cdk1-dependent phosphorylation remains unknown (GharbiAyachi et al., 2010; Mochida et al., 2010) . Nucleated or enucleated oocytes were treated with 1-MeAde, and 40 min later (equivalent to metaphase of meiosis I) conventional (A) and phos-tag (B) SDS-PAGE followed by anti-Arpp19 immunoblots were performed. Entry into M phase was confirmed by loss of pTyr15 in Cdk1. (C) Gwl restores enucleation effects on the phosphorylation pattern of Arpp19. Enucleated immature oocytes were uninjected or injected with recombinant Gwl (recGwl; inactive, WT; control kinase-dead, KD) and then treated with 1-MeAde. Phos-tag analysis as in B was performed in C-F. (D) Inhibition of Cdk1 prevents Arpp19 phosphorylation in enucleated oocytes. Enucleated oocytes were treated with 1-MeAde in the presence of the Cdk inhibitor roscovitine (20 µM; Ros) or control DMSO. (E) Arpp19 becomes phosphorylated not only on the Gwl site, Ser106, but also on a possible Cdk1 site, Ser69, after entry into M phase in nucleated oocytes. Nucleated immature oocytes were injected with wild type (WT) or each mutant of Arpp19 proteins (4A [T42A, S69A, S106A, and T155A], 2A [S69A and S106A], and 3A [T42A, S106A, and T155A]), and then treated with 1-MeAde. The 3A mutant, which retains Ser69, showed the band upshift. (F) Cyclin B-Cdk1 directly phosphorylates Arpp19 on Ser69 in vitro. Each of wild-type Arpp19 and the mutant proteins described in E was mixed with purified cyclin B-Cdk1. Wild type and the 3A mutant, both of which retain Ser69, showed the band upshift. (G and H) Arpp19 is phosphorylated on Ser69 in vivo after entry into M phase both in nucleated and enucleated oocytes. Nucleated (G) or enucleated (H) oocytes were treated with 1-MeAde, and oocyte extracts were prepared at the indicated times. Anti-Arpp19 immunoprecipitates were analyzed with anti-pSer69 antibody. Entry into M phase was confirmed by loss of pTyr15 in Cdk1 and by histone H1 kinase (H1K) activation. Enucleation was confirmed by loss of MCM2, a nuclear protein marker (H). Brightness, contrast, and gamma settings were adjusted in the image presentation.
phosphorylated by cyclin B-Cdk1 alone reduced the PP2AB55 activity to approximately half of controls with unphosphory lated Arpp19, whereas the phosphorylations by Gwl or by Gwl + cyclin B-Cdk1 were slightly or significantly more effective, respectively. The Ala mutant of Arpp19Ser69, which had been treated with cyclin B-Cdk1, exhibited little reduction in PP2A B55-inhibiting activity. These observations indicate that the Ser69 phosphorylation of Arpp19 by cyclin B-Cdk1 converts Arpp19 into a functional inhibitor against PP2AB55, at least to some extent. Indicated amounts of recombinant GST-B55 (recB55; left) or recombinant Arpp19 (recArpp19; right) and/or five starfish oocytes were loaded and analyzed by Western blot. The concentrations of endogenous B55 (left) and Arpp19 (right) were calculated to be 0.3 and 1.3 µM, respectively, from protein amounts of 46 and 72 pg per 3 nl of oocyte volume. Asterisk, nonspecific bands. (C) Arpp19 phosphorylated in vitro on Ser69 by cyclin B-Cdk1 suppresses PP2A-B55 activity. Wild-type Arpp19 or the Ser69Ala (S69A) mutant protein was thiophosphorylated by cyclin B-Cdk1, Gwl, or both kinases, and then mixed with recombinant PP2A-B55 heterotrimers. Final concentrations of PP2A-B55 and Arpp19 in the mixture were adjusted to be 50 and 200 nM, respectively. After removal of kinases, phosphatase activity of PP2A-B55 was measured using Fizzy-pSer50 as a substrate. Each error bar indicates mean value ± SD from three independent experiments.
Starfish Arpp19 contains three putative sites (Thr42, Ser69, and Thr155) for cyclin B-Cdk1 phosphorylation (Fig. S1 ). In fact, treatment of enucleated oocytes with the Cdk inhibitor roscovi tine mostly prevented phosphorylation of Arpp19 after 1MeAde addition (Fig. 2 D) . We made several nonphosphorylatible mu tants of Arpp19 at the three putative Cdk1 sites (Thr42, Ser69, and Thr155) and the conserved Gwl site (Ser106). Injection of wildtype or mutant Arpp19 proteins into nucleated immature oocytes revealed that, after 1MeAde addition, exogenous Arpp19 was phosphorylated at Ser69 (a Cdk1 site) and Ser106 (the Gwl site) during M phase (Fig. 2 E) . Consistently, purified cyclin B-Cdk1 phosphorylated in vitro only the mutant (3A) of Arpp19 containing intact Ser69 but not mutants containing Ser69Ala (Fig. 2 F) . Thus, Arpp19 is most likely to be phosphorylated on Ser69 by cyclin B-Cdk1, besides Ser106 phosphorylation by Gwl.
To confirm that endogenous Arpp19 is phosphorylated on Ser69 in M phase, we prepared anti-phosphoSer69 of Arpp19 antibody (antipSer69; Fig. S2 , C and D). In nucleated oocytes, phosphorylation on Ser69 of Arpp19 became detectable when cyclin B-Cdk1 was activated after 1MeAde addition (Fig. 2 G) . In enucleated oocytes as well, Arpp19 was phosphorylated on Ser69 in M phase (Fig. 2 H) . We concluded that endogenous Arpp19 is phosphorylated on Ser69 directly by cyclin B-Cdk1, regardless of the presence or absence of Gwl.
Arpp19 phosphorylated on Ser69 by cyclin B-Cdk1 inhibits PP2A-B55
We then investigated the effect of antiArpp19 antibody on the in vitro phosphorylation of Ser69 on Arpp19 by cyclin B-Cdk1. For this purpose, in vitro phosphorylation of Ser69 on Arpp19 by purified cyclin B-Cdk1 (shown in Fig. 2 F) was first con firmed by antipSer69 antibody (Fig. 3 A, left) . Further addition of the antiArpp19 antibody to the reaction mixture inhibited phosphorylation of Ser69 by cyclin B-Cdk1 ( Fig. 3 A, left) , whereas the same antibody did not inhibit Gwlinduced phos phorylation of Ser106 on Arpp19 ( Fig. 3 A, right) . Thus, the in vivo inhibitory effect of antiArpp19 antibody on cyclin B-Cdk1 ac tivation (Fig. 1 ) could be ascribed to prevention of cyclin B-Cdk1 phosphorylation of Ser69 on Arpp19.
How then does the phosphorylation of Arpp19 on Ser69 by cyclin B-Cdk1 contribute to the activation of cyclin B-Cdk1? Because PP2AB55 was presumably downregulated during M phase in enucleated, Gwldeficient oocytes ( Fig. 1 A) , we exam ined the in vitro effect of the Arpp19Ser69 phosphorylation on PP2AB55 activity. For this purpose, a cDNA of the starfish ho mologue for the B55 subunit of PP2A was cloned (Fig. S3) , an antibody was raised against it ( Fig. S2 E) , and endogenous pro tein levels of B55 and Arpp19 in starfish oocytes were determined (Fig. 3 B) . Then, under conditions that reflect the endogenous molar ratio (i.e., 1:4) between B55 and Arpp19, the effect of the Arpp19Ser69 phosphorylation on PP2AB55 activity was ex amined in vitro (Fig. 3 C) . After addition of unphosphorylated Arpp19 or Arpp19 (wild type or mutant) thiophosphorylated by cyclin B-Cdk1, Gwl, or cyclin B-Cdk1 plus Gwl, the phospha tase activity of recombinant PP2AA/B55/C trimer complex was compared by measuring the phosphates released from radio labeled FizzypSer50 (Mochida et al., 2010) . Addition of Arpp19 phosphorylation or a phosphomimetic mutation of at least one family member is required for mitotic progression in all meta zoans. In fruit flies, the equivalent position to Ser69 is a phos phomimetic aspartic acid (Kim et al., 2012) . In C. elegans, which appears not to have a Gwl homologue (Kim et al., 2012) , Cdk1 phosphorylation of Ensa on Ser21 and other sites appears to compensate for the lack of Gwl phosphorylation.
Our results are most simply interpreted as indicating a bi phasic regulation of the activity of Arpp19 in terms of its inhibi tion of PP2AB55 (Fig. 5 ). In the initial stages, phosphorylation on Ser69 by a small population of activated cyclin B-Cdk1 plays a key role in the further autoactivation of larger pools of cyclin B-Cdk1. Activated cyclin B-Cdk1 can then activate Gwl, which then phosphorylates Ser106 on Arpp19, promoting syn ergistic autoactivation of cyclin B-Cdk1 and allowing proper segregation of chromosomes. These different roles of Arpp19 most likely reflect the types or levels of PP2AB55 inhibition caused by the two phosphorylations. More plausibly, various substrates likely have different sensitivities to various levels of PP2AB55 phosphatase activity: it will be intriguing to identify the substrates that exhibit the greater or least sensitivities to the inhibition of PP2AB55 and determine whether a correlation exists with the different cellular roles of Arpp19 phosphorylated at the two sites.
Materials and methods

Starfish oocytes
Starfish Asterina pectinifera (renamed Patiria pectinifera in the 2007 National Center for Biotechnology Information Taxonomy Browser) were collected during the breeding season and kept in laboratory aquaria supplied with circulating seawater at 14°C. Fully grown immature oocytes without follicles were released from isolated ovaries after treatment with calciumfree artificial seawater (Ookata et al., 1992) . These immature oocytes were treated with 1 µM 1-MeAde (Kanatani et al., 1969) to induce meiotic maturation at 20°C in artificial seawater. Microinjection and enucleation were performed as described previously (Kishimoto, 1986) . Starfish oocytes were optically transparent, and hence an enucleated oocyte was easily prepared by suction of the whole germinal vesicle content and its membrane into a micropipette under microscopy. The use of all animals (starfish and rabbits) complied with our institute regulations.
cDNA cloning of starfish Arpp19 and B55
A cDNA clone covering the full-length starfish Arpp19 coding region was isolated by PCR, using first strand cDNA from poly(A) mRNA of immature starfish oocytes and specific primers designed from the 5 and 3 noncoding region of a gene (isotig11736; Human Genome Sequencing Center, Baylor College of Medicine) of another starfish species, Asterina miniata, that was homologous to Xenopus laevis Arpp19: 5-AGTCTTCGCTC-CAGCCACTCC-3 forward and 5-CATCCCCTTCCTCGCCCACT-3 reverse. The PCR products were sequenced and confirmed to be homologous to Arpp19. The GenBank accession number for the cDNA sequence of the starfish A. pectinifera Arpp19 is AB818897. A cDNA of starfish 55-kD B subunit of PP2A (B55) was obtained from the starfish A. pectinifera expressed sequence tag cDNA library (clone ID apg14g01; Gen-Bank accession no. AB818896).
Recombinant proteins
N-Terminal 6×His-tagged and C-terminal FLAG-tagged, full-length recombinant starfish Arpp19 protein was expressed in Escherichia coli BL21 (DE3; Invitrogen) using pET21b (EMD Millipore). Arpp19 protein was purified with Ni-NTA agarose (QIAGEN) and dialyzed against PBS (13.7 mM NaCl, 0.27 mM KCl, 0.75 mM Na 2 HPO 4 , and 0.15 mM KH 2 PO 4 ). Ala mutants on putative phosphorylation sites of Arpp19 (T42A, S69A, S106A, and T155A) were generated with the QuikChange site-directed mutagenesis kit (Agilent Technologies). Primers for each mutation were as follow. T42A: forward, 5-GAAGACAAGCCCGCCCCTCTGCCATTAC-3;
Our results collectively suggest that, in the absence of Gwl, the autoregulatory loop functions most likely through a novel bypass in which active cyclin B-Cdk1 directly phosphory lates Arpp19 on Ser69 to suppress PP2AB55 (see Fig. 5 ). This model explains why Arpp19 is required for full activation of cyclin B-Cdk1 even when Gwl is not present. The implica tion would be that a partial reduction of PP2AB55 activity is sufficient for the autoregulatory activation of cyclin B-Cdk1. In contrast, this is unlikely in frog egg extracts, where Gwl has been reported to be necessary for activation of cyclin B-Cdk1 (Yu et al., 2006) . One interesting possible explanation for this discrepancy between organisms involves the unusual cytoplas mic localization of Gwl in frog oocytes .
Gwl phosphorylation of Arpp19 is required for chromosome segregation
Even though phosphorylation of Arpp19 on Ser106 by Gwl is not essential for the autoregulatory activation of cyclin B-Cdk1, this site (as well as Ser69) is indeed phosphorylated in vivo in M phase of starfish oocytes (see Figs. 1 B and 2 A) . Does this phosphorylation on Ser106 by Gwl play some other critical role in M phase events? To address this question, we examined the behavior of meiotic chromosomes after GVBD in oocytes in which Gwl activation was prevented by injection with a neutral izing antibody against Gwl . We showed pre viously that after 1MeAde is added to such oocytes, Gwl remains unactivated but cyclin B-Cdk1 is fully activated ; hence, Arpp19 is assumed to be phosphorylated on Ser69 but not on Ser106. The Gwlinhibited oocytes failed to segre gate homologous chromosomes at the first polar body formation of meiosis I (Fig. 4, A and C) . Further injection of Arpp19 that had been thiophosphorylated beforehand by Gwl on Ser106 re stored the defect in chromosome segregation, whereas control injection of the wildtype Arpp19, which is assumed to have been phosphorylated on Ser69 but not on Ser106 within the oo cytes, failed to show the restoration effect (Fig. 4, B and C) . Thus the Gwldependent phosphorylation of Arpp19 on Ser106 is required for proper chromosome segregation. Chromosome segregation failure has also been observed in the Scant/Gwl mu tant of Drosophila melanogaster (Yu et al., 2004; Archambault et al., 2007) and in human cells in which Gwl/MASTL has been knocked down Voets and Wolthuis, 2010) . It is most likely that a partial reduction of PP2AB55 activity effected by cyclin B-Cdk1 alone is not sufficient and its further reduction by cyclin B-Cdk1 plus Gwl is required to ensure proper chromosome segregation ( Figs. 3 C and 5) . In other words, the Gwl-Arpp19-PP2AB55 pathway appears to exhibit more impact after nuclear envelope breakdown Álvarez Fernández et al., 2013; Cundell et al., 2013) .
We show here that direct phosphorylation of Arpp19 on Ser69 by cyclin B-Cdk1 is sufficient for full activation of cy clin B-Cdk1 via its autoregulatory loop. The evolutionary implica tions of this finding are of interest. The homologous site for Ser69 of starfish Arpp19 is present in frog Ensa on Thr28, frog Arpp19 on Ser28, human Arpp19 on Ser23, and C. elegans Ensa on Ser21; but it is not present in human Ensa or the single Ensa family member in fruit flies (Fig. S1 ). We propose that Cdk1dependent A and B) Immature starfish oocytes were first injected with HiLyte 488-labeled tubulin (green) and Alexa 568-labeled histone H1 (magenta), and then injected with neutralizing anti-Gwl antibody (anti-Gwl) or control IgG (cont. IgG) along with ZZ-IBB (that can deliver cytoplasmically injected IgG into the nucleus) or uninjected (None). After 1-MeAde addition, live-cell images were obtained using a confocal microscope to monitor formation of the meiosis I spindle. Gwl-inhibited oocytes failed to properly segregate homologous chromosomes (A). This phenotype may be classified into three types, although they overlapped in some cases: lagging (#1, magenta), congressed (#2, yellow), or scattered (#3, blue) chromosomes along with frequently multipolar spindles (asterisks). However, further coinjection into immature oocytes with Arpp19 that had been in vitro thiophosphorylated by Gwl (pS106-Arpp19), but not with wild-type Arpp19 (wt-Arpp19), restored homologous chromosome segregation (B). Time after 1-MeAde addition is indicated in each frame. Arrow, chromosomes; arrowhead, the first polar body. Bars, 5 µm. (C) Quantification of chromosome segregation failure displayed in A and B. Each color corresponds to #1, #2, and #3 in A and B, respectively. Numbers of independent experiments (more than three females) are indicated at each bar.
In vitro phosphorylation of Arpp19
Wild-type and several mutant Arpp19 proteins were mixed with active cyclin B-Cdk1 and/or active Gwl in the presence of 1 mM ATP or 1 mM ATP--S at 25°C for 60 min. Thiophosphorylated Arpp19 was separated from the kinases into the flow-through fraction using the centrifugal filter unit Ultrafree-MC (MW cutoff 30 kD; EMD Millipore), and after buffer exchange, concentrated with Vivaspin 500-10 kD to 1 mg/ml in TBS (50 mM Tris-HCl, pH7.5, and 150 mM NaCl) for phosphatase activity assay or in PBS for injection into oocytes.
In vivo phosphatase activity assay Maltose-binding protein fused with 25 peptide residues containing Ser50 of Fizzy (Fizzy-Ser50) was expressed in E. coli and purified with amylose resin (New England Biolabs, Inc.; Mochida et al., 2009 ). 2 mg/ml of purified Fizzy-Ser50 was completely phosphorylated by starfish cyclin B-Cdk1 at 25°C for 2 h, and then repurified with amylose resin to remove kinase. Fizzy-pSer50 was injected into nucleated or enucleated oocytes (at 0.9 ng/oocyte) at the immature state, just after GVBD, or at a time equivalent to GVBD (enucleated oocytes). Oocytes were collected 15 min later and dissolved in Laemmli's sample buffer (LSB), and the phosphorylation state of Fizzy-Ser50 was analyzed by immunoblots with anti-maltose-binding protein antibody after phos-tag SDS-PAGE.
In vitro phosphatase activity assay
In vitro assay of phosphatase activity was performed using recombinant heterotrimeric PP2A-B55 complex (PP2A-A/B55/C) and its substrate, Fizzy-pSer50, as described previously (Mochida et al., 2010) with a small modification in assay conditions. Fizzy-Ser50 was phosphorylated by the purified starfish cyclin B-Cdk1 as described above in the presence of 1/50 volume of -[ 32 P]ATP (PerkinElmer), followed by removal of the kinase and unincorporated -[ 32 P]ATP with amylose resin. PP2A-B55 and Arpp19 were preincubated for 15 min on ice at the molar ratio 1:4 (final concentrations, 50 and 200 nM, respectively), which reflects the endogenous molar ratio in starfish oocytes. They were then supplemented with Fizzy-pSer50 (5,000 cpm), followed by phosphatase reaction for 30 min at 23°C. The reaction was terminated by adding 5 vol of 10% TCA. After protein precipitation by centrifugation, 15 µl of supernatant was mixed with 20 µl of 5% (wt/vol) ammonium molybdate in 0.5 M H 2 SO 4 and 80 µl of water-saturated 2-methyl-1-propanol/heptane (1:1) to separate released phosphate as phosphomolybdic acid in alcohol. The radioactivity of the organic phase was counted with a liquid scintillation counter (LS6500; Beckman Coulter).
Gwl inhibition and its rescue
To inhibit the activity of nuclear Gwl in vivo, a neutralizing anti-Gwl-C antibody (3 mg/ml, 750 pg) was incubated with ZZ-IBB (10 mg/ml, 500 pg) for 30 min on ice, and then injected into the cytoplasm of immature oocytes as described previously . ZZ-IBB is composed of two synthetic Z domains derived from the IgG-binding domain of protein A and the nuclear localization signal IBB (importin -binding domain of importin ), allowing nuclear accumulation of IgG . To examine whether Arpp19 restored the defect observed in Gwl-inhibited oocytes, either wild-type Arpp19 protein or Arpp19 protein that had been thiophosphorylated by Gwl (pS106-Arpp19; both 2 mg/ml) was microinjected into immature oocytes at sevenfold excess to the endogenous level, along with anti-Gwl antibody plus ZZ-IBB. Depending on batches of oocytes, coinjection of control IgG and ZZ-IBB caused some delay in reaching metaphase. Coinjection of anti-Gwl antibody caused further delay, whereas this additional delay was almost restored by further injection of pS106-Arpp19.
Live-cell images of microtubules and chromosomes
To monitor meiotic spindle assembly and chromosome alignment, each immature oocyte was injected with both 2% oocyte volume of HiLyte-488labeled porcine brain tubulin (2 mg/ml; Cytoskelton, Inc.) in G buffer (100 mM Pipes-KOH, pH 6.9, 1 mM MgSO 4 , 1 mM EGTA, and 1 mM GTP) and with 1% oocyte volume of Alexa 568-labeled histone H1 in PBS (prepared at 1 mg/ml using histone H1 protein [Roche] and Alexa 568 protein labeling kit [Molecular Probes]) as described previously . Live oocytes in artificial seawater were observed with a Fluoview FV1000 confocal microscope (Olympus) using a 40× water-immersion objective lens (UAPON 40×W340; Olympus) at 21°C. Fluoview software was used for acquisition of digital images from the photon detector of the FV1000 system. ImageJ software (National Institutes of Health) was used for Z-stack projection of maximum intensity, trimming, and adjustment of brightness and contrast of the obtained images. The levels of small-dotted noise signals reverse, 5-GTAATGGCAGAGGGGCGGGCTTGTCTTC-3; S69A: forward, 5-GAAGCCTCAGCTCGCCCCTGAAAAGATG-3; reverse, 5-CATCTTTT-CAGGGGCGAGCTGAGGCTTC-3; S106A: forward, 5-GTCAAATATTTT-GACGCTGGGGATTACC-3; reverse, 5-GGTAATCCCCAGCGTCAAAA-TATTTGAC-3; T155A: forward, 5-GACCATCCCAGCCCCTGCCTCCAT AC-3; reverse, 5-GTATGGAGGCAGGGGCTGGGATGGTC-3. Multiple phosphorylation site mutants were generated with combinations of these primers. The PCR products were sequenced to confirm mutagenesis. Each mutant of Arpp19 protein was expressed, purified, and, after buffer exchange, concentrated at 4 mg/ml in PBS with Vivaspin 500-10 kD (Sartorius). These proteins were injected into oocytes at 0.3 ng/oocyte. Histagged B55 protein and GST-tagged B55 protein were expressed in E. coli, and then purified with Ni-NTA agarose (QIAGEN) and glutathione Sepharose (GE Healthcare), respectively.
Preparation of active cyclin B-Cdk1 and active Gwl
Active cyclin B-Cdk1 was purified from meta-I starfish oocytes by Suc1 beads as described previously . In brief, the high speed oocyte extracts (the supernatant after centrifugation at 140,000 g for 40 min) were first batch loaded on p13 Suc1 -Sepharose 4B equilibrated with a buffer containing 80 mM -glycerophosphate, 20 mM EGTA, 15 mM MgCl 2 , 1 mM DTT, and 0.01% Brij35, pH 7.3. The Suc1 beads were then packed into a chromatographic column. After washing the column, starfish cyclin B-Cdk1 was eluted with the same buffer supplemented with 500 mM NaCl and 50% ethylene glycol. Purified cyclin B-Cdk1 fractions were dialyzed against a buffer containing 80 mM -glycerophosphate, 20 mM EGTA, 15 mM MgCl 2 , 1 mM DTT, 10% sucrose, and 0.1% NP-40, pH 7.3. N-Terminal 6×His-tagged, full-length recombinant Gwl proteins (active and inactive rGwl-WT, prepared in the presence or absence of okadaic acid, respectively, and kinase-deficient mutant) were prepared using the Bac-to-Bac Baculovirus expression system (Invitrogen) as described previously . In brief, 96 h after infection with recombinant baculovirus, Sf9 cells were lysed and rGwl was purified with Ni-NTA agarose. To prepare mitotically active rGwl-WT, Sf9 cells were treated with 100 nM okadaic acid for 12 h before harvest according to Yu et al. (2006) . The kinase-deficient mutant of rGwl (rGwl-G52S) was generated with the QuikChange site-directed mutagenesis kit. Purified rGwl was dialyzed against a buffer containing 80 mM NaCl, 1 mM DTT, and 20 mM Hepes, pH 7.5. Figure 5 . Model for the two-step phosphorylation of Arpp19 and the distinct roles of the two phosphorylations in governing M phase. First, phosphorylation on Ser69 by cyclin B-Cdk1 (red line) is involved in the autoregulatory activation of cyclin B-Cdk1. Second, further phosphorylation on Ser106 by Gwl (blue line) is needed for proper chromosome segregation, although it is not essential for the autoactivation. Initial activation corresponds to a trigger that reverses the balance between Cdc25 and Myt1/Wee1 before the first activation of cyclin B-Cdk1. Although molecular identity of the trigger remains elusive in most systems, it is clearly identified as Akt/PKB in the starfish oocyte Kishimoto, 2011) : 1-MeAde causes activation of Akt/PKB, which in turn directly phosphorylates and inhibits Myt1 and phosphorylates and activates Cdc25, thus tipping the balance toward the initial activation of cyclin B-Cdk1. an oocyte extract. For immunoprecipitation, 30 µl of the oocyte extract was incubated with 5 µl of anti-Arpp19 antibody beads for 90 min on ice. Each immunoprecipitate was washed three times with TBS-T, 15 µl of 2× LSB was added, and the samples were boiled for 5 min before electrophoresis.
SDS-PAGE and phos-tag SDS-PAGE SDS-PAGE was performed as described previously . To further separate phosphorylated proteins in SDS-PAGE, phos-tag acrylamide (Wako Chemicals USA) was added to the separation gel (10%, except for 12% in Fig. 3 A) at 22.5 µM with 45 µM MnCl 2 , according to the manufacturer's instructions.
Histone H1 kinase assay
The activity of cyclin B-Cdk1 in oocytes was measured by in vitro phosphorylation of histone H1 as described previously . 1 µl of oocytes extracts were incubated for 30 min at 25°C in a final volume of 10 µl containing 0.3 mg/ml histone H1 (Boehringer Ingelheim) and 0.2 µl of -[ 32 P]ATP. The reaction was terminated by addition of 10 µl of 2× LSB, followed by boiling for 5 min. 10-µl samples were run on 12% SDS-PAGE gel and stained with 0.25% Coomassie brilliant blue R-250. The gels were autoradiographed using an imaging plate with BAS2000 (Fujifilm) .
Statistical analysis
Statistical analyses about averages, standard deviations, and two-tail p-values by paired t tests were performed using Microsoft Excel.
Online supplemental material Fig. S1 shows deduced amino acid sequence of starfish Arpp19. Fig. S2 characterizes anti-starfish Arpp19, anti-pSer106 of Arpp19, anti-pSer69 of Arpp19, and anti-starfish B55 subunit of PP2A antibodies. Fig. S3 shows deduced amino acid sequence of starfish B55 regulatory subunit of PP2A. Online supplemental material is available at http://www.jcb.org/ cgi/content/full/jcb.201307160/DC1. Additional data are available in the JCB DataViewer at http://dx.doi.org/10.1083/jcb.201307160.dv.
